Literature DB >> 31669803

Weighting and reweighting of visual input via head mounted display given unilateral peripheral vestibular dysfunction.

Anat V Lubetzky1, Daphna Harel2, Jennifer Kelly3, Bryan D Hujsak3, Ken Perlin4.   

Abstract

We translated a well-established laboratory paradigm to study sensory integration into a Head-Mounted-Display (HMD). In the current study, a group of 23 individuals with unilateral vestibular dysfunction and 16 age-matched controls observed moving spheres projected from the Oculus Rift. We confirmed increased visual weighting with an unstable surface and decreased visual weighting (i.e., reweighting) with increased visual amplitude. We did not observe significant differences in gains and phases between individuals with vestibular dysfunction and age-matched controls. The vestibular group increased sway in mid and high frequencies significantly more than controls with the change in surface or visual amplitude. Mild visual perturbations within HMDs carry the potential to become a useful portable assessment of postural control in individuals with vestibular disorders.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Head mounted display; Postural control; Sensory integration; Vestibular disorders; Virtual reality

Mesh:

Year:  2019        PMID: 31669803     DOI: 10.1016/j.humov.2019.102526

Source DB:  PubMed          Journal:  Hum Mov Sci        ISSN: 0167-9457            Impact factor:   2.161


  2 in total

1.  Insight into postural control in unilateral sensorineural hearing loss and vestibular hypofunction.

Authors:  Anat V Lubetzky; Jennifer L Kelly; Daphna Harel; Agnieszka Roginska; Bryan D Hujsak; Zhu Wang; Ken Perlin; Maura Cosetti
Journal:  PLoS One       Date:  2022-10-17       Impact factor: 3.752

2.  Postural and Head Control Given Different Environmental Contexts.

Authors:  Anat V Lubetzky; Jennifer L Kelly; Bryan D Hujsak; Jenny Liu; Daphna Harel; Maura Cosetti
Journal:  Front Neurol       Date:  2021-06-03       Impact factor: 4.003

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.